| Literature DB >> 31897262 |
Shaymaa A Abdulameer1, Mohanad N Sahib2, Syed A Syed Sulaiman3, Mohamed A Hassali4.
Abstract
BACKGROUND: osteoporosis and diabetes mellitus are highly prevalent diseases that have potentially devastating effects on health and socioeconomic status.Entities:
Keywords: Attitudes; Cross-Sectional Studies; Diabetes Mellitus; Health Knowledge; Health Literacy; Malaysia; Osteoporosis; Practice; Risk Factors; Type 2
Year: 2019 PMID: 31897262 PMCID: PMC6935538 DOI: 10.18549/PharmPract.2019.4.1636
Source DB: PubMed Journal: Pharm Pract (Granada) ISSN: 1885-642X
Relationships between osteoporosis knowledge levels and patients’ demographic characteristics (N=450)
| Variable | N (%) | Osteoporosis knowledge level N (%) | p† | OKT-M scores Mean (SD) [median] | p‡ | |
|---|---|---|---|---|---|---|
| Low OKT level | High OKT level | |||||
| 300 (66.7%) | 150 (33.3%) | |||||
| Age (years) | 0.520 | 0.462 | ||||
| <45 | 11 (2.4%) | 7 (63.6%) | 4 (36.4%) | 12.82 (4.19) [14] | ||
| 45-54 | 78 (17.3%) | 47 (60.3%) | 31 (39.7%) | 13.19 (3.84) [13] | ||
| 55-64 | 166 (36.9%) | 116 (69.9%) | 50 (30.1%) | 12.40 (3.83) [13] | ||
| ≥65 | 195 (43.3%) | 130 (66.7%) | 65 (33.3%) | 12.41 (4.31) [12] | ||
| Gender | 0.424 | 0.327 | ||||
| Male | 231 (51.3%) | 150 (64.9%) | 81 (35.1%) | 12.75 (3.94) [13] | ||
| Female | 219 (48.7%) | 150 (68.5%) | 69 (31.5%) | 12.34 (4.17) [12] | ||
| Race | 0.075 | 0.068 | ||||
| Malay | 127 (28.2%) | 75 (59.1%) | 52 (40.9%) | 13.17 (3.94) [13] | ||
| Chinese | 204 (45.3%) | 139 (68.1%) | 65 (31.9%) | 12.17 (4.35) [12] | ||
| Indian | 119 (26.4%) | 86 (72.3%) | 33 (27.7%) | 12.55 (3.58 [12] | ||
| Educational levels | 0.000[ | 0.000[ | ||||
| <12 years | 285 (63.3%) | 215 (75.4%) | 70 (24.6%) | 11.76 (3.99) [12] | ||
| ≥ 12 years | 165 (36.7%) | 85 (51.5%) | 80 (48.5%) | 13.93 (3.80) [14] | ||
| Marital Status | 0.713 | 0.747 | ||||
| Single | 70 (15.6%) | 48 (68.6%) | 22 (31.4%) | 12.69 (3.29) [12] | ||
| Not single | 380 (84.4%) | 252 (66.3%) | 128 (33.7%) | 12.53 (4.18) [13] | ||
| Monthly income | 0.000a | 0.000a | ||||
| Less than RM 2000 | 330 (73.3%) | 242 (73.3%) | 88 (26.7%) | 12.02 (3.81) [12] | ||
| More than RM 2000 | 120 (26.7%) | 58 (48.3%) | 62 (51.7%) | 14.03 (4.35) [15] | ||
| Menopausal status (N=219) | 0.331 | 0.737 | ||||
| Premenopausal | 25 (11.4%) | 15 (60.0%) | 10 (40.0%) | 12.56 (4.29) [13] | ||
| Postmenopausal | 194 (88.6%) | 135 (69.6%) | 59 (30.4%) | 12.31 (4.17) [12] | ||
| Employment status | 0.069 | 0.022a | ||||
| Working | 192 (42.7%) | 119 (62.0%) | 73 (38.0%) | 13.10 (3.99) [13] | ||
| Not working | 258 (57.3%) | 181 (70.2%) | 77 (29.8%) | 12.14 (4.06) [12] | ||
| Family history of osteoporosis | 0.274 | 0.136 | ||||
| No | 392 (87.1%) | 265 (67.60%) | 127 (32.4%) | 12.45 (4.09) [12] | ||
| Yes | 58 (12.9%) | 35 (60.30%) | 23 (39.7%) | 13.24 (3.79) [13] | ||
| Family history of fracture | 0.004a | 0.007a | ||||
| No | 359 (79.8%) | 251 (69.90%) | 108 (30.1%) | 12.28 (4.17) [12] | ||
| Yes | 91 (20.2%) | 49 (53.80%) | 42 (46.2%) | 13.63 (3.39) [13] | ||
| Smoking habit | 0.124 | 0.028a | ||||
| Not smoking | 318 (70.7%) | 219 (68.9%) | 99 (31.1%) | 12.24 (4.17) [12] | ||
| Smoking | 132 (29.3%) | 81 (61.4%) | 51 (38.6%) | 13.30 (3.66) [13] | ||
| Alcohol habit | 0.033a | 0.005a | ||||
| Non alcoholic | 356 (79.1%) | 246 (69.1%) | 110 (30.9%) | 12.28 (4.16) [12] | ||
| Alcoholic | 94 (20.9%) | 54 (57.4%) | 40 (42.6%) | 13.60 (3.47) [13] | ||
| BMI (Kg/m2) | 0.374 | 0.349 | ||||
| Non-obese (BMI ≤23 kg/m2) | 98 (21.8%) | 69 (70.4%) | 29 (29.6%) | 12.32 (4.09) [12] | ||
| Obese (BMI >23kg/m2) | 352 (78.2%) | 231 (65.6%) | 121 (34.4%) | 12.62 (4.05) [13] | ||
† Association, Chi-square test,
p<0.05; ‡ Difference;
Mann-Whitney U test;
Kruskal-Wallis test;a p< 0.05
BMI: Body mass index; SD: standard deviation
Relationships between osteoporosis knowledge levels and diabetes-related variables (N=450)
| Variable | N (%) | Osteoporosis knowledge level N (%) | ||||
|---|---|---|---|---|---|---|
| Low OKT level 300 (66.7%) | High OKT level 150 (33.3%) | |||||
| Diabetes duration (years) | 0.622 | 0.473 | ||||
| < 5 | 175 (38.9%) | 111 (63.40%) | 64 (36.6%) | 12.70 (4.03) [13] | ||
| 5 – 9 | 125 (27.8%) | 85 (68.0%) | 40 (32.0%) | 12.68 (3.95) [13] | ||
| 10 – 14 | 89 (19.8%) | 60 (67.4%) | 29 (32.6%) | 12.58 (4.31) [12] | ||
| ≥ 15 | 61 (13.6%) | 44 (72.1%) | 17 (27.9%) | 11.84 (3.98) [12] | ||
| Therapy type | 0.093 | 0.003[ | ||||
| Mono therapy | 115 (25.6%) | 84 (73.0%) | 31 (27.0%) | 11.63 (4.32) [11.00] | ||
| Combined therapy | 335 (74.4%) | 216 (64.5%) | 119 (35.5%) | 12.87 (3.92) [13] | ||
| Insulin use | 0.190 | 0.035[ | ||||
| With insulin | 67 (14.9%) | 40 (59.7%) | 27 (40.3%) | 13.48 (3.93) [13] | ||
| Without insulin | 383 (85.1%) | 260 (67.9%) | 123 (32.1%) | 12.39 (4.06) [12] | ||
| Diabetic complication (DC) | 0.175 | 0.614 | ||||
| Positive (with DC) | 330 (73.3%) | 226 (68.5%) | 104 (31.5%) | 12.50 (3.99) [12] | ||
| Negative (without DC) | 120 (26.7%) | 74 (61.7%) | 46 (38.3%) | 12.69 (4.23) [13] | ||
| Co-morbidities | 0.656 | 0.704 | ||||
| Positive (with Co-morbidities) | 426 (94.7%) | 285 (66.9%) | 141 (33.1%) | 12.54 (4.09) [12] | ||
| Negative (without Co-morbidities) | 24 (5.3%) | 15 (62.5%) | 9 (37.5%) | 12.71 (3.26) [13] | ||
| Glycaemic control (HbA1c) | 0.938 | 0.801 | ||||
| Good HbA1c (< 6.5) | 107 (23.8%) | 71 (66.4%) | 36 (33.6%) | 12.37 (3.81) [13] | ||
| Poor HbA1c (≥ 6.5) | 343 (76.2%) | 229 (66.8%) | 114 (33.2%) | 12.61 (4.13) [12] | ||
† Association, Chi-square test,
P<0.05
‡ Difference,
Mann-Whitney U test,
Kruskal-Wallis test,a P<0.05
Frequency and percent of lipid profile and blood pressure groups among the studied population (N=450)
| Variable | Mean (SD) [Median] | N (%) | OKT-M score Mean (SD) [Median] | p-value |
|---|---|---|---|---|
| TC | 5.25 (0.91) [5.23] | 0.439 | ||
| Good < 5.2 mmol/L | 216 (48.0%) | 12.41(4.27) [12] | ||
| Poor ≥ 5.2 mmol/L | 234 (52.0%) | 12.68(3.86) [13] | ||
| HDLC | 1.19 (0.27) [1.13] | 0.219 | ||
| Good ≥ 1.1 mmol/L | 272 (60.4%) | 12.40 (4.01) [12] | ||
| Poor < 1.1 mmol/L | 178 (39.6%) | 12.78 (4.12) [13] | ||
| LDL C | 3.06 (0.77) [3.0] | 0.614 | ||
| Good ≤ 2.6 mmol/L | 133 (29.6%) | 12.70(4.29) [13] | ||
| Poor > 2.6 mmol/L | 317 (70.4%) | 12.49(3.96) [12] | ||
| TG | 1.77 (1.06) [1.57] | 0.347 | ||
| Good ≤ 1.7 mmol/L | 277 (61.6%) | 12.68(3.96) [13] | ||
| Poor > 1.7 mmol/L | 173 (38.4%) | 12.35(4.20) [12] | ||
| SBP | 136.48 (8.46) [136.67] | 0.283 | ||
| Good ≤ 130 mmHg | 125 (27.8%) | 12.82(3.97) [13] | ||
| Poor > 130 mmHg | 325 (72.2%) | 12.45(4.08) [12] | ||
| DBP | 81.78 (4.88) [80.0] | 0.026[ | ||
| Good ≤ 80 mmHg | 231 (51.3%) | 12.13(3.97) [12] | ||
| Poor > 80 mmHg | 219 (48.7%) | 13.00(4.09) [13] |
Mann-Whitney U test,
P<0.05. TC, total cholesterol; HDLC, high density lipoprotein cholesterol; LDLC, low density lipoprotein cholesterol, TG, triglyceride; SBP, systolic blood pressure; DBP, diastolic blood pressure